Epigenetic Silencing of the RASSF1A Tumor Suppressor Gene through HOXB3-Mediated Induction of DNMT3B Expression
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
SUMMARY The RASSF1A tumor suppressor gene is epigenetically silenced in a variety of cancers. Here we perform a genome-wide human shRNA screen and find that epigenetic silencing of RASSF1A requires the homeobox protein HOXB3. We show that HOXB3 binds to the DNA methyltransferase DNMT3B gene and increases its expression. DNMT3B, in turn, is recruited to the RASSF1A promoter, resulting in hypermethylation and silencing of RASSF1A expression. DNMT3B recruitment is facilitated through interactions with Polycomb repressor complex 2 and MYC, which is bound to the RASSF1A promoter. Mouse xenograft experiments indicate that the oncogenic activity of HOXB3 is due, at least in part, to epigenetic silencing of RASSF1A. Expression analysis in human lung adenocarcinoma samples reveals that RASSF1A silencing strongly correlates with over-expression of HOXB3 and DNMT3B. Analysis of human cancer cell lines indicates that the RASSF1A epigenetic silencing mechanism described here may be common in diverse cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · cited 1×
“Significantly, EZH2 is overexpressed in several types of primary and metastatic cancers, including lung cancers, and has been shown to contribute to the malignant properties of cancer cells (Breuer et al., 2004; Tonini et al., 2008; Varambally et al., 2002).”
BackgroundThe Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · cited 7×
“ChIP assays were performed as previously described (Raha et al., 2005) using the following antibodies: a-HOXB3 rabbit polyclonal (Santa Cruz, sc28606); a-DNMT3B rabbit polyclonal (Abcam, ab2851); a-Pol II mouse monoclonal (Covance, 8WG16); a-EZH2 mouse monoclonal (Cell Signaling Technology, AC22); a-H3K27-Me3 rabbit p…”
BackgroundInfluentialWajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 7×
“Quantitative RT-PCR Analysis Total RNA was isolated and reverse transcription was performed as previously described (Wajapeyee et al., 2008), followed by qPCR using Platinum SYBR Green qPCR SuperMix-UDG with Rox (Invitrogen).”
MethodInfluentialSelf-citationHox genes in hematopoiesis and leukemogenesis
Argiropoulos, B., & Humphries, R. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210760 · Cited by 492 · cited 3×
“Because overexpression of HOX proteins and chromosomal translocations involving HOX proteins have been implicated in a variety of malignancies (reviewed in Argiropoulos and Humphries, 2007; Grier et al., 2005), we elected to investigate the role of HOXB3 in RASSF1A silencing in greater detail.”
BackgroundStat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells
Kidder, B. L., Yang, J., & Palmer, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003932 · Cited by 184 · cited 2×
“For example, analysis of genome-wide occupancy results (Kidder et al., 2008) reveals that, of the 2189 promoters bound by Myc in mouse embryonic stem cells, only 108 ( 5%) are also bound by Polycomb.”
BackgroundKaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153 · cited 1×
“By contrast, knockdown of the retinoblastoma (RB1) protein, a known NSCLC tumor suppressor (reviewed in Kaye, 2002; Wikman and Kettunen, 2006) that is expressed in A549 cells (Figure S8), had no significant effect on tumor growth rate (Figure 5B).”
ResultPolycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila
Goodliffe, J. M., Wieschaus, E., & Cole, M. D. (2005) · Genes & Development · doi:10.1101/gad.1352305 · Cited by 46 · cited 3×
“For example, in both flies and mammalian cell lines, MYC has been shown to autorepress its own transcription, which in both cases requires Polycomb complexes (Goodliffe et al., 2005).”
BackgroundInfluential
Cited by
Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells
Almeida, M. I., Nicoloso, M. S., Zeng, L., Ivan, C., Spizzo, R., Gafà, R., Xiao, L., Zhang, X., Vannini, I., Fanini, F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.047 · Cited by 202
Igarashi, Y., Akiyama, Y., Shimada, S., Watanabe, S., Hatano, M., Kodera, K., Okazaki, K., Tanji, Y., Tsukihara, S., Taniai, T., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2024.101307 · Cited by 10
Trendel, J., Prokofeva, P., Chen, Z. A., Horn, L., Trendel, S., Mema, M., Stuiver, M., Rappsilber, J., & Kuster, B. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag339 · Cited by 3
Metadata
- Authors
- Palakurthy, R. K., Wajapeyee, N., Santra, M. K., Gazin, C., Lin, L., Gobeil, S., & Green, M. R.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 36
- Issue
- 2
- Pages
- 219-230
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2103007980
- Cited by
- 122
- References
- 8
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.